Maria V. Sergeeva - Concepedia

Author

Maria V. Sergeeva

Also Known As

M Sergeeva, M V Sergeeva, M. Sergeeva, M. V. SERGEEVA, M. V. Sergeeva, M.V. Sergeeva, Maria Sergeeva, Maria V Sergeeva, Maria V. SERGEEVA, Maria V. Sergeeva

130

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Research Institute of Influenza Institute for Information Transmission Problems Skolkovo Institute of Science and Technology First Pavlov State Medical University of St. Petersburg Unisys (United States)

About

Maria V. Sergeeva is an author at Research Institute of Influenza specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	471
2	Biochemistry	13	13	574
3	Natural Sciences	6	6	371
4	Engineering	3	3	392
5	Public Health	1	1	22

Maria V. Sergeeva

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Denaturation capacity: a new quantitative criterion for selection of organic solvents as reaction media in biocatalysis Yuri L. Khmelnitsky, Vadim V. Mozhaev, A. B. Belova, European Journal of Biochemistry EngineeringProtein AssemblyProtein Phase SeparationNew Quantitative CriterionProtein Refolding	1991	240
Biocatalytic plastics as active and stable materials for biotransformations Ping Wang, Maria V. Sergeeva, Lilian Lim, Nature Biotechnology BioplasticsEngineeringBioplasticBiochemical EngineeringBiodegradable Polymers	1997	126
Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia Andrey B. Komissarov, Ksenia R. Safina, Sofya K. Garushyants, Nature Communications	2021	112
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19 Oksana V. Stanevich, Evgeniia Alekseeva, Maria V. Sergeeva, Nature Communications	2023	59
Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan Kunsulu Zakaryа, Lespek Kutumbetov, Mukhit Orynbayev, EClinicalMedicine	2021	54
Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin Roman Y. Kotlyarov, Alexandr V. Korotkov, Maria V. Sergeeva, PLoS ONE VaccinationCross-protectionAvian InfluenzaMatrix 2Vaccine Development	2015	52
Lipase-catalyzed transamidation of non-activated amides in organic solvent Maria V. Sergeeva, Vadim V. Mozhaev, Joseph O. Rich, Biotechnology Letters	2000	49
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase Frank Ruebsam, Douglas E. Murphy, Chinh Van Tran, Bioorganic & Medicinal Chemistry Letters Hcv Ns5b PolymeraseBiochemistryTricyclic 5,6-Dihydro-1h-pyridin-2-onesMedicineAntiviral Therapy	2009	43
Peptide synthesis using proteases dissolved in organic solvents Maria V. Sergeeva, Vikram Paradkar, Jonathan S. Dordick Enzyme and Microbial Technology Peptide EngineeringPeptide LibraryBiochemistryPeptide Synthesis	1997	42
Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine Yuefen Zhou, Stephen E. Webber, Douglas E. Murphy, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryViral Polymerase StructureNatural SciencesMedicine	2008	41

Page 1